← Back to catalogue
Research draft

hepatitis

vr.tr.hepatitis · INF.KNW

Let an agent explain hepatitis and its main causes in general terms, relay prevention, vaccination, testing and treatment information from health authorities, and route personal symptoms, results and treatment questions to clinicians.

Thing Registry Information and virtual systems

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify

Researched by: Claude

Purpose and description

Let an agent explain hepatitis and its main causes in general terms, relay prevention, vaccination, testing and treatment information from health authorities, and route personal symptoms, results and treatment questions to clinicians.

Inflammation of the liver, most often caused by viral infection with hepatitis A, B, C, D or E viruses, and also by alcohol, drugs and toxins, autoimmune disease and metabolic conditions; it ranges from acute self-limiting illness to chronic infection leading to cirrhosis and liver cancer, and is a major global public health concern with vaccines available for some forms.

What it is for: Not applicable; a disease.

It can be explain causes and types in general terms; relay prevention and vaccination guidance; relay testing and treatment information from authorities; route personal questions to clinicians.

Distinguishing features

Liver inflammation with many causes

Viral forms differ in transmission and chronicity

Vaccines exist for hepatitis A and B

Chronic forms are treatable and hepatitis C is curable with modern drugs

What it looks like

Not visible as an object; may present with jaundice, fatigue and abdominal symptoms, or no symptoms.

Physical character

chronic hepatitis B and C: hundreds of millions people worldwide - WHO estimates; figures change

incubation: weeks to months time - by virus

How it is recognised

Liver inflammation confirmed by blood tests and clinical assessment

Viral types A to E have different transmission and courses

Cirrhosis and liver cancer are consequences with their own entries

Related models

is a kind of - of the liver

inflammation

affects - the organ

liver

leads to - a consequence of chronic disease

cirrhosis

is prevented by - for hepatitis A and B

vaccine

In practice

Families and kinds

viral hepatitis A, B, C, D and E

alcoholic hepatitis

drug-induced and toxic hepatitis

autoimmune hepatitis

metabolic and fatty liver related hepatitis

Identifiers

ICD-10 B15-B19 and K70-K77 viral and other hepatitis codes

ICD-11 1E50-1E51 and DB9 codes vary by cause

Standards and regulation

WHO guidelines on hepatitis B and C testing and treatment

National immunisation schedules

Notifiable disease reporting rules

Blood and organ donation screening rules

Failure modes and hazards

Undiagnosed chronic infection progressing to cirrhosis and cancer

Transmission through blood, sex, birth and contaminated food or water

Stigma delaying testing

Agents giving personal medical advice

Also called

drug-induced hepatitisgranulomatous hepatitisToxoplasma hepatitisviral hepatitiscytolytic hepatitisEuropean Brown Hare Syndromealcoholic hepatitisanimal hepatitischronic hepatitisNeonatal hepatitisautoimmune hepatitisIdiopathic granulomatous hepatitisTheiler's diseasePost-transfusion hepatitisEpstein-Barr virus hepatitishepatic Torque teno virus infectious diseaseCytomegalovirus hepatitisadenovirus hepatitisRubella virus hepatitisVaricella-zoster virus hepatitisFulminant viral hepatitisHepatitis Xanimal viral hepatitisautoimmune hepatitis type 1

Where this came from

wikidata · CC0 1.0

Also registered as vr.tr.hepatitis

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.

Understand What hepatitis is.

General information.

Causes

Causes and types.

Causes

Causes.

  1. What causes hepatitis, and how do the viral types differ in transmission and course? definition
  2. Is the user asking about their own symptoms or results, which needs a clinician? boundary

Course

Acute and chronic.

Course

Course.

  1. How does acute hepatitis differ from chronic infection, and what are the consequences? definition
  2. Which entry fits cirrhosis or liver cancer? action
Prevent Prevention and testing.

Prevention is public health.

Prevention

Vaccines and hygiene.

Prevention

Prevention.

  1. What vaccines and prevention measures do health authorities recommend? provenance
  2. Which entry fits immunisation schedules? action

Testing

Testing.

Testing

Testing.

  1. Who should be tested according to guidelines, and how is testing accessed? provenance
  2. Which services provide testing locally? action
Treat Treatment and care.

Care is clinical.

Treatment

Treatment.

Treatment

Treatment.

  1. What treatments exist for each type, in general terms from guidelines? provenance
  2. Is the presentation free of personal treatment advice? boundary

Living

Living with hepatitis.

Living

Living.

  1. What support and rights information do health and patient organisations provide? provenance
  2. Which entry fits patient support? action
Public health Epidemiology and policy.

Global burden.

Burden

Epidemiology.

Burden

Burden.

  1. How many people are affected, and what are the elimination targets, from WHO? measurement
  2. Which sources and dates are cited? provenance

Study

Research.

Study

Study.

  1. What research is under way, and which references are standard? provenance
  2. How is hepatitis taught to health workers? action

What the second pass must settle

  • Should each viral type be a separate entry?
  • How should national guidelines be linked?
  • The registry entry has merged aliases including an animal disease; should they be split off?